Approach to the patient presenting with parkinsonism

doi:10.1017/CBO9780511544873.038

37 - Approach to the patient presenting with parkinsonism

from Part VII - Parkinson's and related movement disorders

Published online by Cambridge University Press: 04 August 2010

Anthony E. Lang and

Katie Kompoliti and

M. Flint Beal: Affiliation:
Cornell University, New York
Anthony E. Lang: Affiliation:
University of Toronto
Albert C. Ludolph: Affiliation:
Universität Ulm, Germany
Katie Kompoliti: Affiliation:
Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
Christopher G. Goetz: Affiliation:
Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA

Book contents

Get access

Summary

General symptomatology of patients with parkinsonism

In the nearly 200 years since James Parkinson's original essay on ‘shaking palsy’ (Parkinson, 1817), clinicians have learned that he described a syndrome rather than a specific disease and that Parkinson's has many imitators. As a syndrome, parkinsonism is characterized by tremor, bradykinesia, rigidity and postural reflex compromise. Parkinson's disease is one of many parkinsonian syndromes and is defined by the same clinical signs in association with a distinct type and pattern of cellular degeneration. Parkinsonism can occur as an isolated clinical syndrome, classified as primary when it is due to hereditary or idiopathic causes or secondary when it has another identifiable underlying etiology. When parkinsonism occurs in association with other neurological signs, it is classified as one of the well-defined parkinsonism-plus syndromes or as parkinsonism associated with defined hereditodegenerative disorders (Table 37.1). Parkinson's disease is the archetype of primary parkinsonism. A thorough history and comprehensive examination can usually differentiate Parkinson's disease from other parkinsonian syndromes. Nevertheless, clinicopathological studies have shown that 20% of patients thought clinically to have Parkinson's disease turn out to have pathological cellular changes suggestive of other diagnoses, and 5–10% of parkinsonian subjects with an atypical clinical picture for Parkinson's disease have the typical cellular changes of Parkinson's disease at autopsy (Hughes et al., 2001).

Unilateral tremor is the most common initial symptom resulting in medical consultation for Parkinson's disease.

Type: Chapter
Information: Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 551 - 560

DOI: https://doi.org/10.1017/CBO9780511544873.038 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Agid, Y., Cervera, P., Hirsch, E.et al. (1989). Biochemistry of Parkinson's disease 28 years later: a critical review. Mov. Disord., 4, S126–44CrossRef Google Scholar PubMed

Bennett, D. A., Beckett, L. A., Murray, A. M.et al. (1996). Prevalence of parkinsonian signs and associated mortality in a community population of older people. N. Engl. J. Med., 334, 71–6CrossRef Google Scholar

Bergeron, C., , Davis, A., & Lang, A. E. (1998). Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol., 8, 355–65CrossRef Google Scholar

Bower, J. H., Maraganore, D. M., McDonnell, S. K. & Rocca, W. A. (1997). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology, 49, 1284–8CrossRef Google Scholar PubMed

Bower, J. H., Maraganore, D. M., McDonnell, S. K. & Rocca, W. A. (1999). Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology, 52, 1214–20CrossRef Google Scholar

Brooks, D. J. (1997). Neuroimaging of movement disorders. In Movement Disorders, Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 31–48. New York, NY: McGraw-Hill

Colosimo, C., Albanese, A., Hughes, A. J., Bruin, V. M. & Lees, A. J. (1995). Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch. Neurol., 52, 294–8CrossRef Google Scholar PubMed

Dickson, D. W. (1999). Tau and synuclein and their role in neuropathology. Brain Pathol., 9, 657–61CrossRef Google Scholar PubMed

Duda, J. E., Lee, V. M. & Trojanowski, J. Q. (2000). Neuropathology of synuclein aggregates. J. Neurosci. Res., 61, 121–73.0.CO;2-4>CrossRef Google Scholar PubMed

Duguid, J. R., Paz, R. & DeGroot, J. (1986). Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann. Neurol., 20, 744–7CrossRef Google Scholar PubMed

Feany, M. B. & Dickson, D. W. (1996). Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann. Neurol., 40, 139–48CrossRef Google Scholar PubMed

Galvin, J. E., Lee, V. M. & Trojanowski, J. Q. (2001), Synucleinopathies: clinical and pathological implications. Arch. Neurol., 58, 186–90CrossRef Google Scholar PubMed

Gelb, D. J., Oliver, E. & Gilman, S. Research diagnostic criteria for Parkinson's disease. In Parkinson's Disease: Anatomy, Pathology, and Therapy, ed. M. Streifler, A. Korczyn, E. Melamed & M. Youdim. New York: Raven Press

Gilman, S., Low, P. A. & Quinn, N. P. (1999). Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci., 163, 94–8CrossRef Google Scholar

Golbe, L. I. (1994). The epidemiology of PSP. J. Neural. Transm. Suppl 42, 263–73CrossRef Google Scholar PubMed

Golbe, L. I. (1996). The epidemiology of progressive supranuclear palsy. Adv. Neurol., 69, 25–31Google Scholar PubMed

Golbe, L. I. (1997). Progressive supranuclear palsy. In Movement Disorders: Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 279–95. New York, NY: McGraw-Hill

Gorell, J. M., Ordidge, R. J., Brown, G. G., Deniau, J. C., Buderer, N. M. & Helpern, J. A. (1995). Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology, 45, 1138–43CrossRef Google Scholar PubMed

Hauw, J. J., Daniel, S. E., Dickson, D., et al. (1994). Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology, 44, 2015–19CrossRef Google Scholar

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatr., 55, 181–4CrossRef Google Scholar PubMed

Hughes, A. J., Ben-Shlomo, Y., , Daniel, S. E. & Lees, A. J. (2001). What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study 1992. Neurology, 57, S34–8Google Scholar PubMed

Hutton, M., Lendon, C. L., Rizzu, P.et al. (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702–5CrossRef Google Scholar PubMed

Jankovic, J. (1989). Parkinsonism-plus syndromes. Mov. Disord., 4 Suppl 1, S95–119CrossRef Google Scholar PubMed

Jellinger, K. A. (1998). Neuropathology of movement disorders. Neurosurg. Clin. N. Am., 9, 237–62Google Scholar PubMed

Jellinger, K. A. (1996). The neuropathologic diagnosis of secondary parkinsonian syndromes. In Parkinson's Disease, ed. L. Battistin, G. Scarlato, T. Caraceni & S. Ruggieri, pp. 293–303. Philadelphia, PA: Lippincott-Raven

Lee, V. M., Goedert, M., & Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annu. Rev. Neurosci., 24, 1121–59CrossRef Google Scholar PubMed

Litvan, I., Agid, Y., Jankovic, J.et al. (1996). Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome). Neurology, 46, 922–30CrossRef Google Scholar

Litvan, I., Goetz, C. G. & Jankovic, J. (1997). What is the accuracy of the clinical diagnosis of multiple system atrophy. Arch. Neurol., 54, 937–44CrossRef Google Scholar PubMed

Litvan, I., MacIntyre, A., Goetz, C. G.et al. (1998). Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch. Neurol., 55, 969–78CrossRef Google Scholar PubMed

Mayeux, R., Stern, Y., Rosen, J. & Leventhal, J. (1981). Depression, intellectual impairment, and Parkinson disease. Neurology, 31, 645–50CrossRef Google Scholar PubMed

Mayeux, R., Chen, J., Mirabello, E.et al. (1990). An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology, 40, 1513–17CrossRef Google Scholar PubMed

Magalhaes, M., Wenning, G. K., Daniel, S. E. & Quinn, N. P. (1995). Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease – a retrospective comparison. Acta Neurol. Scand., 91, 98–102CrossRef Google Scholar PubMed

Mastaglia, F. L., Grainger, K., Kee, F., Sadka, M. & Lefroy, R. (1973). Progressive supranuclear palsy (the Steele–Richardson–Olszewski syndrome): clinical and electrophysiological observations in eleven cases. Proc. Aust. Assoc. Neurol., 10, 35–44Google Scholar PubMed

Moleman, P., Janzen, G., Bargen, B. A., Kappers, E. J., Pepplinkhuizen, L. & Schmitz, P. I. (1986). Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol. Am. J. Psychiatr., 143, 232–4Google Scholar PubMed

Morris, H. R., Lees, A. J. & Wood, N. W. (1999). Neurofibrillary tangle parkinsonian disorders – tau pathology and tau genetics. Mov. Disord., 14, 731–63.0.CO;2-J>CrossRef Google Scholar PubMed

Parkinson, J. (1817). An Essay on the Shaking Palsy. London, Whittingham and Rowland for Sherwood, Neely and Jones

Pastakia, B., Polinsky, R., Di Chiro, G., Simmons, J. T., Brown, R. & Wener, L. (1986). Multiple system atrophy (Shy–Drager syndrome): MR imaging. Radiology, 159, 499–502CrossRef Google Scholar PubMed

Paulson, H. L. & Stern, M. B. (1997). Clinical manifestations of Parkinson's disease. In Movement Disorders: Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 183–99. New York, NY: McGraw-Hill

Pfeiffer, R. F. (1997). Wilson's disease. In Movement Disorders, Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 623–37. New York, NY: McGraw-Hill

Polymeropoulos, M. H., Lavedan, C., Leroy, E.et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science, 276, 2045–7CrossRef Google Scholar

Quinn, N. (1989). Multiple system atrophy – the nature of the beast. J. Neurol. Neurosurg. Psychiatr., Suppl, 78–89CrossRef Google Scholar PubMed

Rajput, A. H., Offord, K. P., Beard, C. M. & Kurland, L. T. (1989). Epidemiology of parkinsonism: incidence, classification, and mortality. Ann. Neurol., 16, 278–82CrossRef Google Scholar

Rajput, A. H., Rozdilsky, B., & Rajput, A., (1991). Accuracy of clinical diagnosis in parkinsonism – a prospective study. Can. J. Neurol. Sci., 18, 275–8CrossRef Google Scholar PubMed

Rutledge, J. N., Hilal, S. K., Silver, A. J., Defendini, R. & Fahn, S. (1987). Study of movement disorders and brain iron by MR. Am. J. Roentgenol., 149, 365–79CrossRef Google Scholar PubMed

Saito, T. (1981). An assessment of efficiency in potential screening for Wilson's disease. J. Epidemiol. Commun. Hlth., 35, 274–80CrossRef Google Scholar PubMed

Savoiardo, M., Strada, L., Girotti, F.et al. (1990). Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology, 174, 693–6CrossRef Google Scholar PubMed

Savoiardo, M., Halliday, W. C., Nardocci, N.et al. (1993). Hallervorden–Spatz disease: MR and pathologic findings. Am. J. Neuroradiol., 14, 155–62Google Scholar

Savoiardo, M., Girotti, F., Strada, L. & Ciceri, E. (1994). Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J. Neural. Transm. Supp., 42, 93–110CrossRef Google Scholar PubMed

Savoiardo, M., Grisoli, M. & Girotti, F. (2000). Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. Adv. Neurol. 82, 197–208Google Scholar PubMed

Schrag, A., Ben-Shlomo, Y. & Quinn, N. P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet, 354, 1771–5CrossRef Google Scholar PubMed

Shulman, L. M. & Weiner, W. J. (1997). Multiple-system atrophy. In Movement Disorders, Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 297–306. New York, NY: McGraw-Hill

Snow, B. J., Vingerhoets, F. J., Langston, J. W., Tetrud, J. W., Sossi, V. & Calne, D. B. (2000). Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J. Neurol. Neurosurg. Psychiatr., 68, 313–16CrossRef Google Scholar PubMed

Tanner, C. M. & Goldman, S. M. (1996). Epidemiology of Parkinson's disease. Neurol. Clin., 14, 317–35CrossRef Google Scholar PubMed

Trojanowski, J. Q. & Lee, V. M. (2000). ‘Fatal attractions’ of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. NY Acad. Sci., 924, 62–7CrossRef Google Scholar

Vanacore, N., Bonifati, V., Fabbrini, G.et al. (2001a). Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol. Sci., 22, 97–9CrossRef Google Scholar

Vanacore, N., Bonifati, V., Colosimo, C.et al. (2001b). Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol. Sci., 22, 101–3CrossRef Google Scholar

Wassenaer-van Hall, H. N., Heuvel, A. G., Algra, A., Hoogenraad, T. U. & Mali, W. P. (1996). Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology, 198, 531–6CrossRef Google Scholar PubMed

Vidailhet, M., Rivaud, S., Gouider-Khouja, N.et al. (1994). Eye movements in parkinsonian syndromes. Ann. Neurol., 35, 420–6CrossRef Google Scholar PubMed

Wakabayashi, K., Oyanagi, K., Makifuchi, T.et al. (1994). Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol. (Berl.), 87, 545–53CrossRef Google Scholar PubMed

Weiner, W. J. & Lang, A. E. (1989). Movement Disorders: A Comprehensive Survey. New York, NY: Futura Publishing Company

Wenning, G. K., Ben-Shlomo, Y., Hughes, A., , Daniel, S. E., Lees, A. & Quinn, N. P. (2000). What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?J. Neurol. Neurosurg. Psychiatr., 68, 434–40CrossRef Google Scholar PubMed

Yamanouchi, H. & Nagura, H. (1997). Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke, 28, 965–9CrossRef Google Scholar PubMed